189 related articles for article (PubMed ID: 34200809)
1. Is the Concurrent Use of Sorafenib and External Radiotherapy Feasible for Advanced Hepatocellular Carcinoma? A Meta-Analysis.
Rim CH; Park S; Shin IS; Yoon WS
Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34200809
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and feasibility of surgery and external radiotherapy for hepatocellular carcinoma with portal invasion: A meta-analysis.
Lee HA; Seo YS; Shin IS; Yoon WS; Lee HY; Rim CH
Int J Surg; 2022 Aug; 104():106753. PubMed ID: 35798205
[TBL] [Abstract][Full Text] [Related]
3. The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies.
Rim CH; Kim CY; Yang DS; Yoon WS
Cancer Manag Res; 2018; 10():3305-3315. PubMed ID: 30233246
[TBL] [Abstract][Full Text] [Related]
4. Salvage External Beam Radiotherapy after Incomplete Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review.
Yang DS; Park S; Rim CH; Yoon WS; Shin IS; Lee HA
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684036
[No Abstract] [Full Text] [Related]
5. Radiotherapy for bone metastases of hepatocellular carcinoma: a hybrid systematic review with meta-analyses.
Rim CH; Park S; Yoon WS; Shin IS; Park HC
Int J Radiat Biol; 2023; 99(3):419-430. PubMed ID: 35758976
[TBL] [Abstract][Full Text] [Related]
6. Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis.
Rim CH; Lee JS; Kim SY; Seong J
JHEP Rep; 2023 Jan; 5(1):100594. PubMed ID: 36561128
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies.
Long Y; Liang Y; Li S; Guo J; Wang Y; Luo Y; Wu Y
Radiat Oncol; 2021 Apr; 16(1):68. PubMed ID: 33832536
[TBL] [Abstract][Full Text] [Related]
8. External beam radiotherapy for unresectable hepatocellular carcinoma.
Abdel-Rahman O; Elsayed Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011314. PubMed ID: 28267205
[TBL] [Abstract][Full Text] [Related]
9. Clinical feasibility and efficacy of stereotactic body radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of observational studies.
Rim CH; Kim HJ; Seong J
Radiother Oncol; 2019 Feb; 131():135-144. PubMed ID: 30773180
[TBL] [Abstract][Full Text] [Related]
10. Local Treatment of Hepatocellular Carcinoma with Oligometastases: A Systematic Review and Meta-Analysis.
Kim S; Lee J; Rim CH
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444577
[TBL] [Abstract][Full Text] [Related]
11. External beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: A meta-analysis and systemic review.
Rim CH; Kim CY; Yang DS; Yoon WS
Radiother Oncol; 2018 Oct; 129(1):123-129. PubMed ID: 29606524
[TBL] [Abstract][Full Text] [Related]
12. Concurrent Sorafenib and Radiotherapy versus Radiotherapy Alone for Locally Advanced Hepatocellular Carcinoma: A Propensity-Matched Analysis.
Liu CM; Huang BS; Yen YH; Wang YM; Huang EY; Hsu HC; Huang TT; Yang YH; Cheng JY
J Hepatocell Carcinoma; 2021; 8():963-973. PubMed ID: 34434903
[TBL] [Abstract][Full Text] [Related]
13. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
14. Impact of Intrahepatic External Beam Radiotherapy in Advanced Hepatocellular Carcinoma Patients Treated with Tyrosine Kinase Inhibitors.
Goh MJ; Park HC; Yu JI; Kang W; Gwak GY; Paik YH; Lee JH; Koh KC; Paik SW; Sinn DH; Choi MS
Liver Cancer; 2023 Oct; 12(5):467-478. PubMed ID: 37901765
[TBL] [Abstract][Full Text] [Related]
15. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study.
Zhao JD; Liu J; Ren ZG; Gu K; Zhou ZH; Li WT; Chen Z; Xu ZY; Liu LM; Jiang GL
Radiat Oncol; 2010 Feb; 5():12. PubMed ID: 20149262
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
Chen J; He K; Han Y; Guo L; Su K; Wu Z
Ann Hepatol; 2022; 27(4):100710. PubMed ID: 35430357
[TBL] [Abstract][Full Text] [Related]
17. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta-analysis.
Lee HA; Park S; Seo YS; Yoon WS; Shin IS; Rim CH
J Hepatobiliary Pancreat Sci; 2021 Dec; 28(12):1031-1046. PubMed ID: 33179421
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy.
Kim PH; Choi SH; Kim JH; Park SH
Korean J Radiol; 2019 Mar; 20(3):385-398. PubMed ID: 30799569
[TBL] [Abstract][Full Text] [Related]
19. Sorafenib with or without concurrent transarterial chemoembolization in patients with advanced hepatocellular carcinoma: The phase III STAH trial.
Park JW; Kim YJ; Kim DY; Bae SH; Paik SW; Lee YJ; Kim HY; Lee HC; Han SY; Cheong JY; Kwon OS; Yeon JE; Kim BH; Hwang J
J Hepatol; 2019 Apr; 70(4):684-691. PubMed ID: 30529387
[TBL] [Abstract][Full Text] [Related]
20. Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma.
Yada M; Masumoto A; Motomura K; Tajiri H; Morita Y; Suzuki H; Senju T; Koyanagi T
World J Gastroenterol; 2014 Sep; 20(35):12581-7. PubMed ID: 25253961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
